Brief: Brickell Biotech Reports Fourth Quarter And Full Year 2020 Financial Results
09/03/2021 22:42
March 9 (Reuters) - Brickell Biotech Inc BBI.O :
* BRICKELL BIOTECH REPORTS FOURTH QUARTER AND FULL YEAR
2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* BRICKELL BIOTECH INC - QTRLY LOSS PER SHARE $0.15
Source text for Eikon: ID:nGNX7vVmyw
Further company coverage: BBI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fresh Tracks Therapeutics
See all newsBrief: Fresh Tracks Therapeutics Announces Second Adjournment Of Special Meeting Of Stockholders
Brief: Fresh Tracks Therapeutics Intends To Seek Judicial Dissolution If Liquidation And Approved By Stockholders
Brief: Fresh Tracks Therapeutics Q3 EPS USD 0.32
Brief: Fresh Tracks Therapeutics Inc On October 10 Received A Notice From Listing Qualifications Department Of Nasdaq
U.S. STOCKS ON THE MOVE-Gold miners, Goosehead Insurance, FedEx